Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin to prevent postoperative delirium after complex cardiac surgery
NL-OMON61019Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of regular human insulin in delirium, sponsored by Radboud University Medical Center. Primary endpoints: Feasibility, Tolerability and 1 more. Started Apr 2026; status: completed.
02
Drugs
regular human insulin
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON61019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61019.